VCS Trademark

Trademark Overview

On Thursday, May 13, 2021, a trademark application was filed for VCS with the United States Patent and Trademark Office. The USPTO has given the VCS trademark a serial number of 79315690. The federal status of this trademark filing is REGISTERED as of Tuesday, December 27, 2022. This trademark is owned by AURINIA PHARMACEUTICALS INC.. The VCS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis
vcs

General Information

Serial Number79315690
Word MarkVCS
Filing DateThursday, May 13, 2021
Status700 - REGISTERED
Status DateTuesday, December 27, 2022
Registration Number6932613
Registration DateTuesday, December 27, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAURINIA PHARMACEUTICALS INC.
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressCA
Party NameAURINIA PHARMACEUTICALS INC.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressCA
Party NameAURINIA PHARMACEUTICALS INC.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressCA

Trademark Events

Event DateEvent Description
Monday, May 1, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 7, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 7, 2023FINAL DISPOSITION PROCESSED
Monday, March 27, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, January 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, December 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 27, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 21, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Monday, October 10, 2022NOTIFICATION PROCESSED BY IB
Wednesday, September 21, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 21, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, August 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, August 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 7, 2022REFUSAL PROCESSED BY IB
Tuesday, February 15, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 15, 2022REFUSAL PROCESSED BY MPU
Wednesday, January 26, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 25, 2022NON-FINAL ACTION WRITTEN
Saturday, January 22, 2022ASSIGNED TO EXAMINER
Saturday, July 24, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, July 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 15, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

nephritis focal segmental glomerulosclerosis lupus disorders preparations treatment kidney pharmaceutical